The ZAP-IT study is evaluating the safety and effectiveness of #Azenosertib (ZN-c3) in combination with carboplatin and pembrolizumab in metastatic #TripleNegativeBreastCancer.
For more info call 877-338-7425 or visit: www.dana-farber.org/clinical-tri... #TNBC #BreastCancer #MetastaticBreastCancer